scholarly article | Q13442814 |
P2093 | author name string | Dipali Sharma | |
Neeraj K Saxena | |||
P2860 | cites work | Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence | Q37081272 |
LKB1; linking cell structure and tumor suppression | Q37333592 | ||
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis | Q38361016 | ||
Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells | Q39936443 | ||
Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer | Q40182792 | ||
Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. | Q40200727 | ||
Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells | Q40283150 | ||
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. | Q40453964 | ||
Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer–stromal cell interactions | Q40630211 | ||
Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: Effect of estrogen and progesterone | Q41623563 | ||
AdipoQ is a novel adipose-specific gene dysregulated in obesity | Q42813232 | ||
Preadipocytes stimulate breast cancer cell growth | Q42820435 | ||
Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization | Q42835415 | ||
Adiponectin and protection against type 2 diabetes mellitus | Q44290932 | ||
Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics | Q46381308 | ||
Serum adiponectin and leptin levels in Taiwanese breast cancer patients. | Q46600194 | ||
Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma | Q71842674 | ||
Association of serum adiponectin levels with breast cancer risk | Q79342715 | ||
LKB1 protein expression in human breast cancer | Q79755572 | ||
Adiponectin and leptin expression in primary ductal breast cancer and in adjacent healthy epithelial and myoepithelial tissue | Q79786571 | ||
Low plasma adiponectin levels predict progression of coronary artery calcification | Q81378144 | ||
MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm | Q24296287 | ||
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 | ||
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD | Q24305094 | ||
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin | Q24564272 | ||
Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth | Q28211693 | ||
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase | Q28258611 | ||
Analysis of the LKB1-STRAD-MO25 complex | Q28294900 | ||
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action | Q28505765 | ||
The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma | Q28573021 | ||
Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome | Q28586196 | ||
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes | Q28590335 | ||
Cancer metastasis: building a framework | Q29616783 | ||
Adipose tissue as an endocrine organ | Q29620407 | ||
Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells | Q33264493 | ||
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice | Q34118282 | ||
LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells | Q34155989 | ||
Adiponectin and Metabolic Syndrome | Q34269072 | ||
Adiponectin and breast cancer risk | Q34303243 | ||
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). | Q34377772 | ||
Adiponectin and cancer: a systematic review | Q34506490 | ||
Molecular links between obesity and breast cancer | Q34530905 | ||
Adiponectin: a link between obesity and cancer | Q34549919 | ||
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice | Q35108391 | ||
Breast cancer and obesity: an update | Q35147502 | ||
Adiponectin: A novel adipokine linking adipocytes and vascular function | Q35794441 | ||
The AMP-activated protein kinase pathway--new players upstream and downstream. | Q35930365 | ||
New roles for the LKB1-->AMPK pathway. | Q36076064 | ||
Adipose tissue, adipokines, and inflammation | Q36114223 | ||
Effects of adiponectin on breast cancer cell growth and signaling | Q36614699 | ||
Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer | Q36766440 | ||
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression | Q36885845 | ||
P433 | issue | 3 | |
P304 | page(s) | 358-362 | |
P577 | publication date | 2010-07-17 | |
P1433 | published in | Cell Adhesion and Migration | Q15817193 |
P1476 | title | Metastasis suppression by adiponectin: LKB1 rises up to the challenge | |
P478 | volume | 4 |
Q38684517 | ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis |
Q64945853 | Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease. |
Q92854261 | Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk |
Q26799865 | Cross-Talk between Adiponectin and IGF-IR in Breast Cancer |
Q34040946 | Design and development of a peptide-based adiponectin receptor agonist for cancer treatment |
Q64075830 | Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using a mass spectrometry-based method |
Q36849638 | Evolving role of adiponectin in cancer-controversies and update |
Q38217467 | Gene of the month. AMP kinase (PRKAA1). |
Q90392625 | Glitazone loaded fat enhances adiponectin production and inhibits breast cancer cell proliferation |
Q40509533 | Hypoxia-Induced Upregulation of miR-132 Promotes Schwann Cell Migration After Sciatic Nerve Injury by Targeting PRKAG3. |
Q37868986 | LKB1 signaling in advancing cell differentiation |
Q38153628 | Leptin and adiponectin: emerging therapeutic targets in breast cancer |
Q89598674 | Leptin, Adiponectin, and Sam68 in Bone Metastasis from Breast Cancer |
Q34338949 | Linking adiponectin and autophagy in the regulation of breast cancer metastasis |
Q64245167 | Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications |
Q38900947 | Obesity and cancer: inflammation bridges the two. |
Q35154969 | Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion? |
Q38597253 | Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review. |
Search more.